Malaysian Genomics Resource Centre

Equities

MGRC

MYQ0155OO000

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
0.405 ^MYR	-1.22%		-3.57%	-8.99%

05-23	Malaysian Genomics Resource Trims Attributable Loss in Q1 as Revenue Soars	MT
05-23	Malaysian Genomics Resource Centre Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Rinani Group acquired 5.85% stake in Malaysian Genomics Resource Centre Berhad.

July 13, 2023

Rinani Group acquired 5.85% stake in Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) on July 14, 2023.

Rinani Group completed the acquisition of 5.85% stake in Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) on July 14, 2023.

Latest news about Malaysian Genomics Resource Centre

Malaysian Genomics Resource Trims Attributable Loss in Q1 as Revenue Soars	05-23	MT
Malaysian Genomics Resource Centre Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024	05-23	CI
Malaysian Genomics Resource, Twistcode Technologies In Bioinformatics Tie-Up Talks	05-07	MT
Malaysian Genomics Resource Centre Berhad Announces Aswath A/L Ramakrishnan, Independent and Non Executive Director Was Not Reelected by Shareholders At the Annual General Meeting	04-29	CI
Malaysian Genomics Resource, DE Cell Forge Strategic Alliance	04-18	MT
Malaysian Genomics Resource, Universiti Sains Malaysia Tie Up for Genetics Study	03-14	MT
Malaysian Genomics Resource Centre Berhad Announces Collaboration Agreement with Universiti Sains Malaysia	03-13	CI
Malaysian Genomics Resource Centre Berhad Announces Redesignation of Encik Muhammad Badri Bin Hussin to Chief Operating Officer from Director	03-07	CI
Malaysian Genomics Resource Centre Berhad Announces Appointment of Mohammad Hasni Bin Ibrahim as Independent and Non Executive Member of Audit Committee	03-04	CI
Malaysian Genomics Resource Centre Berhad Announces Resignation of Muhammad Badri Bin Hussin as Independent and Non Executive Member of Audit Committee	03-04	CI
Malaysian Genomics Resource Centre Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-28	CI
Malaysian Genomics Resource Centre Berhad Reports Earnings Results for the Eighteen Months Ended December 31, 2023	02-28	CI
Malaysian Genomics Resource Centre Berhad Appoints Mohammad Hasni Bin Ibrahim as Independent and Non Executive Director	02-02	CI
Malaysian Genomics Resource Centre Berhad Appoints Datuk Wira Muhammad Faizal Bin Zainol as Independent and Non Executive Director	02-02	CI
Malaysian Genomics Resource Centre Berhad Announces Re-Designation of Aswath A/L Ramakrishnan as A Non-Audit and Risk Management Committee Member	12-15	CI
Malaysian Genomics Resource Centre Berhad Reports Earnings Results for the Third Quarter Ended September 30, 2023	11-28	CI
Malaysian Genomics to Deploy AntChain Blockchain Technology	11-09	MT
Malaysian Genomics Unit, Dynamic Prestige Consultancy to Operate Dialysis Centers	11-09	MT
Genotec Sdn Bhd announced that it expects to receive funding from Malaysian Genomics Resource Centre Berhad	11-07	CI
Malaysian Genomics Resource Centre Changes Financial Year End to December 31	26/10/23	MT
Malaysian Genomics Resource Centre Berhad Announces Change in Financial Year End from 30 June to 31 December	25/10/23	CI
Malaysian Genomics Resource Centre Berhad Appoints Encik Muhammad Badri Bin Hussin, Age 50, as Member of Audit Committee, Date of Change 25 Oct 2023	25/10/23	CI
Malaysian Genomics Resource Centre Berhad Announces Appointment of Encik Muhammad Badri Bin Hussin as Independent and Non Executive Director	20/10/23	CI
Malaysian Genomics Resource Centre Berhad Announces Appointment of Encik Mohamad Ruzaini Bin Hamzah as Independent and Non Executive Director	17/10/23	CI
Malaysian Genomics Resource Centre Berhad Announces Resignation of Encik Sasha Omar Firdaus Bin Aamir Nordin as Chief Executive Officer	13/09/23	CI

Chart Malaysian Genomics Resource Centre

Duration

Period

Chart Malaysian Genomics Resource Centre

More charts

Company Profile

Malaysian Genomics Resource Centre Berhad is a Malaysia-based company, which is engaged in providing personalized and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services, as well as investment holding. Its services include Genome Sequencing Services, Genome Analysis Services, Genetic Screening Services and Cancer Immunotherapy. Its whole genome sequencing (WGS) is carried out to obtain the sequence of the entire genome from any eukaryotic or prokaryotic organism. This includes plant, animal, microbial, and human genomes. It offers both de novo sequencing and resequencing as part of its WGS service. Its Genome analysis includes services, such as bioinformatics, trait analysis, and trio sequencing. Its Genetic screening includes Dtect, which offers a range of test panels designed to screen for genetic markers in an individualâs deoxyribonucleic acid (DNA). Its Cancer Immunotherapy includes chimeric antigen receptor (CAR) T-Cell immunotherapy.

Sector

Healthcare Facilities & Services

Calendar

26/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
MALAYSIAN GENOMICS RESOURCE CENTRE	-8.99%	11.81M
SONIC HEALTHCARE LIMITED	-24.66%	7.76B
RADNET, INC.	+68.65%	4.33B
SYNLAB AG	-3.15%	2.64B
DR. LAL PATHLABS LIMITED	+3.74%	2.63B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-46.17%	2.16B
NEOGENOMICS, INC.	-15.27%	1.75B
FLEURY S.A.	-22.12%	1.46B
METROPOLIS HEALTHCARE LIMITED	+13.62%	1.17B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-43.81%	1.14B

Medical & Diagnostic Laboratories